Document is current
Any future updates will be listed below
-
Authors
Černoša, Jasna
Volkar, Jelka Meglič
Poljak, Mario
Perme, Maja Pohar
Lazarus, Jeffrey Victor
Matičič, Mojca
-
Funding
Funding for this research was provided by:
Slovenian Research and Innovation Agency (P3-0083)
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 28 January 2025
First Online: 13 February 2025
Declarations
:
: The study was approved by the Slovenian National Medical Ethics Committee (number 0120–622/2020/11).
: Not applicable.
: Jeffrey Victor Lazarus acknowledges support to ISGlobal from grant CEX2023-0001290-S, funded by MCIN/AEI/10.13039/501100011033, and the ´Generalitat de Catalunya´, through the CERCA programme, outside of the submitted work. Jeffrey Victor Lazarus acknowledges grants to ISGlobal from AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Madrigal, MSD, Novo Nordisk, Pfizer, and Roche Diagnostics, consulting fees from Echosens, NovoVax, GSK, Novo Nordisk, and Pfizer, and payment or honoraria for lectures from AbbVie, Echosens, Gilead Sciences, Janssen, Moderna, MSD, Novo Nordisk, and Pfizer, outside of the submitted work.
